FDA
A New Headset to Help With Depression Is Now Available in the US
The device made by Flow Neuroscience is approved by the FDA and could help people get off antidepressants--but it costs $2,200. An at-home wearable for the treatment of depression is now available by prescription in the US. With roughly one in six American adults taking an antidepressant medication, Swedish firm Flow Neuroscience is positioning its device as an alternative to traditional drugs. But at the current four-figure price tag, it might take a while for the futuristic-looking headset to catch on with patients. Worn on the forehead for 30 minutes a day and operated with an app, the device provides low-intensity electrical stimulation to the left frontal lobe of the brain, an area involved in regulating mood and emotions.
How AI could transform cancer treatment and medicine
This material may not be published, broadcast, rewritten, or redistributed. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset . Powered and implemented by FactSet Digital Solutions . Mutual Fund and ETF data provided by LSEG . Asked Siri to call your bank? Floating solar panels could save cities millions. Amazon's Alexa for Shopping can now verify suspicious messages Should you use a separate computer for online banking? Tech companies begging for regulation seems like'Trojan horse,' Vance says Americans are right to be scared over'God in a box,' AI CEO says AI policy expert dismisses Big Tech regulation calls: 'We should see through this' AI agents are'hacking out of the container' despite best efforts to prevent it, expert warns'Totally legitimate' to be concerned about AI: Mollie Hemingway Iran opening'second front' with Houthis in Yemen, Rep Crawford warns White House advisor calls on tech leaders to'stop pretending' over AI threat Kyrsten Sinema: Trump has been'tremendous' on AI data centers CEO of Sellas Life Sciences Angelos Stergiou explains how AI is revolutionizing medicine by enabling precision medicine in cancer treatment.
Health Leaders Talk Expanding Access to Specialty Care
Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. When there are breakthrough technologies like xenotransplants, or novel cancer therapies, they're transformative for diseases and conditions once thought incurable--but they can only save lives if the people that need them can access them. On September 10, TIME hosted the third annual TIME100 Health Leadership Forum in New York City, bringing together the TIME and TIME100 Health communities to discuss equity, longevity, and solution-driven care.
It's Head Lice Season. Here's What to Know
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
Why Food Keeps Making Everybody Sick This Summer
While Trump administration cuts have contributed to Americans' gastrointestinal distress, there are also deeper issues that make the US food supply chain susceptible to parasites and bacteria outbreaks. This summer, every meal feels like a risk. Just as the US is recovering from a major cyclospora outbreak stemming from tainted iceberg lettuce, salmonella has turned up in jalapeรฑos, eggs, and even dog food. The jalapeรฑo-related outbreak is now responsible for at least 431 illnesses and 57 hospitalizations in more than two dozen states. Meanwhile, a dual-pathogen outbreak of E. coli and salmonella linked to alfalfa sprouts has affected 55 people across 15 states.
Mounjaro Is Now Approved to Lower the Risk of Heart Events
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial
Moderna and Merck's personalized mRNA cancer vaccine reduced melanoma recurrence and metastasis in a Phase 3 trial. The companies plan to seek FDA approval.
Who Is Heidi Overton, Trump's Nominee to Lead the FDA?
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?
A robot could eventually conduct your blood draw at the doctor's office
The US Food and Drug Administration has approved a new product aimed at automating blood draws in outpatient situations. Aletta is a standalone robotic device capable of drawing blood from a patient's arm. It uses near-infrared light and Doppler ultrasound to identify a vein and then automates the other processes of a blood draw, such as applying a tourniquet, inserting and disposing of a needle and placing a bandage on the patient. A trained phlebotomist must begin the procedure and oversee the device while it is in use, but a single person can monitor up to three Aletta robots at once. "Blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists." said Michelle Tarver, director of the FDA's Center for Devices and Radiological Health. The approval for Aletta was granted based on clinical data showing it was capable of successful blood draws at rates comparable to or better than a phlebotomist.
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?